1/98
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
Allograft
Tissue from a genetically dissimilar donor → higher rejection risk.
Graft vs Host Disease
Rare in solid organ transplant: donor immune cells attack the host.
Symptoms of Rejection
Fever, malaise, pain at incision, oliguria, hypertension, edema, vasculitis, progressive organ failure, and arterial narrowing.
Immunosuppressants
Medications required for life after renal transplant.
Triple Therapy
Corticosteroid + Antimetabolite + Calcineurin Inhibitor.
Rituximab
Targets B cells for immune modulation.
IVIG
Normalizes immune system, risk of anaphylaxis.
Risk Factors for Infection
Aggressive immunosuppression.
Hyperacute rejection
Occurs in less than 24 hours.
Chronic organ rejection
Progressive failure of the organ and fibrosis of blood vessels.
V-Tach
>180 bpm; With pulse → amiodarone or cardioversion; No pulse → CPR, shock, epi, amio.
AFib
Damage to the atria, inefficient emptying of atria, No P waves, irregular rhythm, risk for stroke.
Atrial Flutter
P wave, Sawtooth waves, risk stroke.
SVT
140-150 bpm; Tx = vagal maneuvers → adenosine → cardioversion.
PVCs
Caused by caffeine, nicotine, stress, ischemia, hypoxia, and electrolyte imbalance.
Bigeminy
Every other heartbeat.
Couplet
2 PVCs in a row.
Run
3 PVCs in a row.
Multifocal PVCs
PVCs that don't look the same.
Unifocal PVCs
PVCs that look the same.
VFib
No cardiac output; Tx = CPR, shock, epi, amiodarone.
Asystole
Flatline; Tx = CPR, epi, Hs & Ts; Do not shock.
Sinus bradycardia
A condition characterized by a slower than normal heart rate, often caused by lower metabolic need, hypothyroidism, or beta blockers.
Sinus tachycardia
A condition characterized by a faster than normal heart rate, often triggered by pain, stimulants, or dehydration.
PAC
Premature Atrial Contraction caused by stimulants, electrolyte imbalances (potassium), or cardiac ischemia, leading to a skipped heartbeat.
3rd degree Heart block
A condition where there is no relationship between P wave and R wave, indicating no conduction between the SA and AV nodes.
PR interval
The time interval between the onset of atrial depolarization and the onset of ventricular depolarization, normally ranging from 0.12 to 0.20 seconds.
Risk Factors for cardiac issues
Includes CAD, MI, electrolyte imbalance, stimulants, and dig toxicity.
Amiodarone
A medication used for atrial fibrillation, ventricular tachycardia, and ventricular fibrillation.
Adenosine
A medication used for supraventricular tachycardia (SVT) with a short half-life.
Digoxin
A medication used for rate control in atrial fibrillation.
Warfarin
An anticoagulant used for stroke prevention in atrial fibrillation.
Sickle Cell Disease (SCD)
A genetic condition caused by HbS leading to sickling of cells, triggered by cold and lack of oxygen.
Symptoms of SCD
Includes pain crisis, anemia, jaundice, priapism, and stroke risk.
Crisis manifestations in SCD
Includes vaso-occlusive pain, splenic sequestration, and aplastic crisis.
Treatment for SCD
Includes oxygen, IV fluids, opioids, transfusions, and hydroxyurea.
CBC findings in SCD
Low hemoglobin, hematocrit, and RBC count; high reticulocyte and WBC count; normal MCU and platelet.
Diagnosis of SCD
Includes blood smear to reveal sickle cells, hemoglobin electrophoresis, and DNA analysis.
Nursing Interventions for SCD
Includes pain management, hydration, oxygen, infection prevention, and cardiovascular and neuro assessment.
Leukemia
A malignant proliferation of white blood cells.
Symptoms of Leukemia
Includes frequent infections, enlarged lymph nodes, liver and spleen, weakness, fatigue, fever, night sweats, and bleeding.
Treatment for Leukemia
Includes chemotherapy, stem cell transplant, and monoclonal antibodies such as rituximab.
Diagnosis of Leukemia
Includes bone marrow biopsy showing a large number of immature leukocytes.
Risk Factors for Leukemia
Includes radiation, benzene exposure, family history, and immunodeficiency.
Bone marrow biopsy
Large number of immature leukocytes.
Nursing Interventions for Leukemia
Neutropenic precautions. Monitor bleeding & infection. Chemo safety & patient/family support.
Lymphoma
Malignancy of lymphatic system (Hodgkin vs Non-Hodgkin). Presents as a solid tumor.
Symptoms of Lymphoma
Painless lymph node swelling, fever, night sweats, weight loss.
Clinical Manifestation of Lymphoma
Enlarged, nontender, firm and movable lymph nodes in the neck, axillary or groin area.
Reed Sternberg Cells
Characteristic cells found in Hodgkin lymphoma.
Treatment for Lymphoma
Chemo, radiation, stem cell transplant, rituximab.
Medications for Lymphoma
Rituximab, IVIG.
Risk Factors for Lymphoma
Immunodeficiency, EBV, family history.
Nursing Interventions for Lymphoma
Monitor for tumor lysis syndrome. Manage fatigue, infection prevention. Psychosocial support.
Pacemakers
Only for sinus bradycardia unresponsive to atropine.
Stroke Risk
Highest with AFib/flutter.
ACLS Sequence
Assess responsiveness → CPR/shock/meds.
PVC Causes
Stimulants, ischemia, hypoxia, dig toxicity.
Erythropoietin alfa
↑ RBCs; monitor Hgb, BP.
Hydroxyurea
Sickle cell; ↑ HbF, monitor CBC.
Milrinone
Inotrope for HF, monitor BP, arrhythmias.
Vasopressin
For shock; potent vasoconstrictor.
Nitroglycerin
Vasodilator for chest pain; SL works fast, lowers BP.
Corticosteroids
A class of steroid hormones produced in the adrenal cortex.
Antimetabolites
Substances that interfere with the metabolic processes of cells.
Antiproliferative drugs
Drugs that prevent the reproduction of B and T cells.
Cell cycle specific
Drugs that attack at very specific phases in the cell cycle.
Azathioprine
A medication used as an immunosuppressant.
Mycophenolic acids
Includes mycophenolate mofetil, used as an immunosuppressant.
Calcineurin Inhibitors
Drugs that inhibit the proliferation of helper T cells and the expression of cytokines.
Cyclosporine
A calcineurin inhibitor used in kidney transplants.
Tacrolimus
A calcineurin inhibitor used in kidney transplants.
Chronic nephrotoxicity
A side effect associated with calcineurin inhibitors.
Monoclonal Antibodies
Lab-made antibodies designed to react directly against certain proteins.
Synergy
The interaction of two or more agents to produce a combined effect greater than the sum of their separate effects.
Patient Characteristics
Factors that influence patient care including stability, vulnerability, resiliency, and complexity.
Stability
The current status of a patient.
Vulnerability
The risk associated with a patient's condition.
Resiliency
The ability to bounce back with coping mechanisms and return to functioning.
Complexity
The intricate entanglement of two or more systems (body, family therapies).
Novice to Expert theory
A framework describing the progression of skills and confidence in practice.
Novice
A beginner who lacks confidence and requires continual cues.
Advanced beginner
A practitioner with marginally acceptable performance and prior experience.
Competent
A practitioner who is efficient, coordinated, and confident in their actions.
Proficient
A charge nurse who sees the whole patient and learns from experiences.
Expert
A practitioner who understands the whole picture and can handle any situation.
Clinical judgement
Assessing a situation based on education and experience.
Collaboration
Working with others to promote well-being.
Clinical inquiry
Guided by the question 'why'.
Transfused platelets
Not beneficial because they are rapidly destroyed in the body.
Multiple myeloma
A condition characterized by an imbalance leading to hypercalcemia.
Hodgkin lymphoma
A type of cancer characterized by the presence of Reed Sternberg cells.
Atropine
Used to treat symptomatic bradycardia.
Restrictive cardiomyopathy
A condition where scar tissue or deposits harden the heart and inhibit relaxation between beats.
Hematopoiesis
The process of blood cell formation occurring in the liver and spleen.
RBC production
Requires vitamin B12 and folic acid to make more red blood cells.
Anemia
A condition characterized by a deficiency of red blood cells.
Hypoproliferative anemia
A defect in the production of red blood cells.
Hemolytic anemia
Characterized by the excess destruction of red blood cells.